Product Overview Product feature summary

The FastPack IP PSA Immunoassay, for use on the FastPack IP System, allows any testing facility to produce point-of-care results in 12 minutes with less than one minute of hands-on time.

Features & Benefits:

• • Quantitative Measurement of total PSA
• • Lower Limit of 0.04 ng/mL
• • Upper Limit of 50 ng/mL
• • Results in 12 minutes

Specifications Product specifications and dimensions

• Brand
  FastPack IP
• CLIA Classification
  Moderately Complex
• Item
  Test Kit
• Item Type
  PSA Immunoassay
• Quantity
  1/kt

Catalog Description As seen in our print catalog

The ability to test for prostate specific antigen (PSA) has revolutionized the diagnosis and management of prostate cancer. It is highly recognized that PSA testing plays a fundamental role in the early detection and monitoring of prostate cancer. The FastPack^® IP Total Immunoassay is a chemiluminescent immunoassay for the in-vitro quantitative determination of PSA in human serum and plasma as an aid in the management of patients with prostate cancer. Designed for use with the FastPack^® IP System.